Syngene International Limited Cash Flow Conversion Efficiency
Syngene International Limited cash flow conversion efficiency. Based on the latest financial reports, Syngene International Limited (SYNGENE) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-451.00 Million ≈ $-4.88 Million USD) by net assets (Rs47.35 Billion ≈ $512.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Syngene International Limited (2010–2025)
Cash flow conversion efficiency of Syngene International Limited from 2010 to 2025. This chart illustrates how Syngene International Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SYNGENE stock price for real-time trading data and today's change.
Syngene International Limited Cash Flow Conversion Ratio Explained
Syngene International Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Syngene International Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Syngene International Limited ranked by their cash flow conversion efficiency. Also see market cap of Syngene International Limited for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NCC AB (publ)
ST:NCC-B
|
-0.008x |
|
Zhuzhou CRRC Times Electric Co. Ltd
F:ZTX
|
0.069x |
|
SJW Group Common Stock
NYSE:SJW
|
0.031x |
|
Sonos Inc
NASDAQ:SONO
|
-0.170x |
|
Nayax Ltd
NASDAQ:NYAX
|
0.085x |
|
Genting Malaysia Bhd
KLSE:4715
|
0.065x |
|
Sanxiang Advanced Materials
SHG:603663
|
0.046x |
|
Innovex International, Inc
NYSE:INVX
|
0.019x |
Annual Cash Flow Conversion Efficiency for Syngene International Limited (2010–2025)
The table below shows the annual cash flow conversion efficiency of Syngene International Limited from 2010 to 2025. Review how much free cash does Syngene International Limited generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs47.27 Billion ≈ $511.19 Million |
Rs11.68 Billion ≈ $126.27 Million |
0.247x | +0.93% |
| 2024-03-31 | Rs42.58 Billion ≈ $460.46 Million |
Rs10.42 Billion ≈ $112.70 Million |
0.245x | +5.62% |
| 2023-03-31 | Rs36.18 Billion ≈ $391.27 Million |
Rs8.38 Billion ≈ $90.67 Million |
0.232x | +31.61% |
| 2022-03-31 | Rs32.98 Billion ≈ $356.62 Million |
Rs5.81 Billion ≈ $62.79 Million |
0.176x | -29.16% |
| 2021-03-31 | Rs28.21 Billion ≈ $305.12 Million |
Rs7.01 Billion ≈ $75.83 Million |
0.249x | -20.14% |
| 2020-03-31 | Rs21.76 Billion ≈ $235.30 Million |
Rs6.77 Billion ≈ $73.23 Million |
0.311x | -2.83% |
| 2019-03-31 | Rs19.68 Billion ≈ $212.87 Million |
Rs6.30 Billion ≈ $68.18 Million |
0.320x | +23.48% |
| 2018-03-31 | Rs17.20 Billion ≈ $186.05 Million |
Rs4.46 Billion ≈ $48.25 Million |
0.259x | -7.85% |
| 2017-03-31 | Rs14.13 Billion ≈ $152.82 Million |
Rs3.98 Billion ≈ $43.01 Million |
0.281x | -5.15% |
| 2016-03-31 | Rs10.53 Billion ≈ $113.86 Million |
Rs3.12 Billion ≈ $33.78 Million |
0.297x | +1255.19% |
| 2015-03-31 | Rs8.45 Billion ≈ $91.37 Million |
Rs185.00 Million ≈ $2.00 Million |
0.022x | -95.18% |
| 2014-03-31 | Rs6.59 Billion ≈ $71.30 Million |
Rs3.00 Billion ≈ $32.39 Million |
0.454x | +127.62% |
| 2013-03-31 | Rs5.19 Billion ≈ $56.08 Million |
Rs1.03 Billion ≈ $11.19 Million |
0.200x | -51.53% |
| 2012-03-31 | Rs2.97 Billion ≈ $32.10 Million |
Rs1.22 Billion ≈ $13.22 Million |
0.412x | +13.87% |
| 2011-03-31 | Rs2.21 Billion ≈ $23.87 Million |
Rs798.00 Million ≈ $8.63 Million |
0.362x | -14.05% |
| 2010-03-31 | Rs1.94 Billion ≈ $20.93 Million |
Rs814.00 Million ≈ $8.80 Million |
0.421x | -- |
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more